Polymer testing is a critical component in industries ranging from medical devices to aerospace, ensuring materials meet stringent quality and […]
East Coast vs. West Coast: Where to Find Specialized Polymer Testing in America Read More »
Introduction Nitrosamine impurities have emerged as a critical concern in pharmaceuticals due to their genotoxic and carcinogenic potential. Regulatory agencies, including
Introduction: Why Nitrosamine Testing Services in Canada Are Crucial in 2025 In 2025, nitrosamine impurities remain a key concern for
How to Choose the Right Provider for Nitrosamine Testing Services in Canada Read More »
Introduction: Why Choosing the Best CRO for Nitrosamine Testing in the U.S. Matters In 2025, as regulatory scrutiny surrounding nitrosamine
ResolveMass vs. Other CROs: Choosing the Best CRO for Nitrosamine Testing in the U.S. Read More »
Introduction In 2025, ensuring regulatory compliance in pharmaceutical manufacturing is more crucial than ever. Nitrosamines—known carcinogens—have raised significant concern in
How to Select the Best Nitrosamine Analytical Testing Company in 2025 Read More »
Canada is taking strong strides toward building a more sustainable and circular plastics economy. With national strategies like the Canada-wide
The Role of Polymer Analysis Labs in Canada’s Plastics Sustainability Initiatives Read More »
Shotgun lipidomics, a mass spectrometry-based approach, enables comprehensive analysis of lipid profiles in biological samples. Its direct infusion method allows
As global pharmaceutical regulations tighten around nitrosamine impurities, standard one-size-fits-all testing methods are no longer enough. Drug products with complex
Custom Method Development: A Must-Have for Effective Nitrosamine Testing Read More »
In today’s highly regulated pharmaceutical environment, manufacturers are under pressure to ensure that every product batch is free of harmful
Why You Need a Specialized Nitrosamine Impurity Analysis Lab for Your Pharma Project Read More »
As regulatory demands continue to intensify across North America and globally, pharmaceutical manufacturers are under increasing pressure to ensure their
